Loading…
On the Way for Patients with Prostate Cancer to the Best Use of PSMA
In recent years, the prostate-specific membrane antigen (PSMA) has achieved a significant role in the diagnostics and treatments of patients with prostate cancer [...].
Saved in:
| Published in: | International journal of molecular sciences 2022-02, Vol.23 (5), p.2478 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | cdi_FETCH-LOGICAL-c435t-9f1438bf644dc88f9281927928f0540613429b83d549259e3dad40c44db974fc3 |
| container_end_page | |
| container_issue | 5 |
| container_start_page | 2478 |
| container_title | International journal of molecular sciences |
| container_volume | 23 |
| creator | von Eyben, Finn Edler Bauman, Glenn Kapp, Daniel S Virgolini, Irene Paganelli, Giovanni |
| description | In recent years, the prostate-specific membrane antigen (PSMA) has achieved a significant role in the diagnostics and treatments of patients with prostate cancer [...]. |
| doi_str_mv | 10.3390/ijms23052478 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a567ef2368fa465988ae08a5514ca10a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_a567ef2368fa465988ae08a5514ca10a</doaj_id><sourcerecordid>2638712682</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-9f1438bf644dc88f9281927928f0540613429b83d549259e3dad40c44db974fc3</originalsourceid><addsrcrecordid>eNpdkU1PGzEQhi1UxFe5ca4s9dIDKf5e-1KJhpYigYhUEEdr4rXJRps12E4r_j2GAAqcxvI8ejQzL0IHlHzn3JCjbr7IjBPJRKM30A4VjI0IUc2ntfc22s15TgjjTJottM0lU0YxsoNOLgdcZh7fwAMOMeEJlM4PJeP_XZnhSYq5QPF4DIPzCZf4DP_0ueDr7HEMePL34vgz2gzQZ7__UvfQ9e9fV-M_o_PL07Px8fnICS7LyAQquJ4GJUTrtA6GaWpYU0sgUhBFuWBmqnkrhalzet5CK4ir9NQ0Iji-h85W3jbC3N6lbgHpwUbo7PNHTLcWUulc7y1I1fjAuNIBhJJGa_BEg5RUOKAEquvHynW3nC586-rSCfp30vedoZvZ2_jPakOM0aYKvr0IUrxf1ovYRZed73sYfFxmyxTXDWVKs4p-_YDO4zIN9VRPVNMISqmq1OGKcvXqOfnwNgwl9ilqux51xb-sL_AGv2bLHwGJUqFG</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2637741116</pqid></control><display><type>article</type><title>On the Way for Patients with Prostate Cancer to the Best Use of PSMA</title><source>Publicly Available Content Database</source><source>PubMed Central(OpenAccess)</source><creator>von Eyben, Finn Edler ; Bauman, Glenn ; Kapp, Daniel S ; Virgolini, Irene ; Paganelli, Giovanni</creator><creatorcontrib>von Eyben, Finn Edler ; Bauman, Glenn ; Kapp, Daniel S ; Virgolini, Irene ; Paganelli, Giovanni</creatorcontrib><description>In recent years, the prostate-specific membrane antigen (PSMA) has achieved a significant role in the diagnostics and treatments of patients with prostate cancer [...].</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23052478</identifier><identifier>PMID: 35269620</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Androgen receptors ; Androgens ; Animal models ; Antigens ; Cancer therapies ; Clinical trials ; Computed tomography ; Conflicts of interest ; FDA approval ; Humans ; Ligands ; Male ; Metastasis ; Molecular structure ; n/a ; Nuclear medicine ; Patients ; Positron emission ; Positron emission tomography ; Prostate cancer ; Prostate-Specific Antigen ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - therapy ; Radiation therapy ; Signal transduction ; Tomography ; Urology</subject><ispartof>International journal of molecular sciences, 2022-02, Vol.23 (5), p.2478</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c435t-9f1438bf644dc88f9281927928f0540613429b83d549259e3dad40c44db974fc3</cites><orcidid>0000-0001-7097-6170 ; 0000-0002-2631-4652</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2637741116/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2637741116?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35269620$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>von Eyben, Finn Edler</creatorcontrib><creatorcontrib>Bauman, Glenn</creatorcontrib><creatorcontrib>Kapp, Daniel S</creatorcontrib><creatorcontrib>Virgolini, Irene</creatorcontrib><creatorcontrib>Paganelli, Giovanni</creatorcontrib><title>On the Way for Patients with Prostate Cancer to the Best Use of PSMA</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>In recent years, the prostate-specific membrane antigen (PSMA) has achieved a significant role in the diagnostics and treatments of patients with prostate cancer [...].</description><subject>Androgen receptors</subject><subject>Androgens</subject><subject>Animal models</subject><subject>Antigens</subject><subject>Cancer therapies</subject><subject>Clinical trials</subject><subject>Computed tomography</subject><subject>Conflicts of interest</subject><subject>FDA approval</subject><subject>Humans</subject><subject>Ligands</subject><subject>Male</subject><subject>Metastasis</subject><subject>Molecular structure</subject><subject>n/a</subject><subject>Nuclear medicine</subject><subject>Patients</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>Prostate cancer</subject><subject>Prostate-Specific Antigen</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Radiation therapy</subject><subject>Signal transduction</subject><subject>Tomography</subject><subject>Urology</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkU1PGzEQhi1UxFe5ca4s9dIDKf5e-1KJhpYigYhUEEdr4rXJRps12E4r_j2GAAqcxvI8ejQzL0IHlHzn3JCjbr7IjBPJRKM30A4VjI0IUc2ntfc22s15TgjjTJottM0lU0YxsoNOLgdcZh7fwAMOMeEJlM4PJeP_XZnhSYq5QPF4DIPzCZf4DP_0ueDr7HEMePL34vgz2gzQZ7__UvfQ9e9fV-M_o_PL07Px8fnICS7LyAQquJ4GJUTrtA6GaWpYU0sgUhBFuWBmqnkrhalzet5CK4ir9NQ0Iji-h85W3jbC3N6lbgHpwUbo7PNHTLcWUulc7y1I1fjAuNIBhJJGa_BEg5RUOKAEquvHynW3nC586-rSCfp30vedoZvZ2_jPakOM0aYKvr0IUrxf1ovYRZed73sYfFxmyxTXDWVKs4p-_YDO4zIN9VRPVNMISqmq1OGKcvXqOfnwNgwl9ilqux51xb-sL_AGv2bLHwGJUqFG</recordid><startdate>20220224</startdate><enddate>20220224</enddate><creator>von Eyben, Finn Edler</creator><creator>Bauman, Glenn</creator><creator>Kapp, Daniel S</creator><creator>Virgolini, Irene</creator><creator>Paganelli, Giovanni</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7097-6170</orcidid><orcidid>https://orcid.org/0000-0002-2631-4652</orcidid></search><sort><creationdate>20220224</creationdate><title>On the Way for Patients with Prostate Cancer to the Best Use of PSMA</title><author>von Eyben, Finn Edler ; Bauman, Glenn ; Kapp, Daniel S ; Virgolini, Irene ; Paganelli, Giovanni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-9f1438bf644dc88f9281927928f0540613429b83d549259e3dad40c44db974fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Androgen receptors</topic><topic>Androgens</topic><topic>Animal models</topic><topic>Antigens</topic><topic>Cancer therapies</topic><topic>Clinical trials</topic><topic>Computed tomography</topic><topic>Conflicts of interest</topic><topic>FDA approval</topic><topic>Humans</topic><topic>Ligands</topic><topic>Male</topic><topic>Metastasis</topic><topic>Molecular structure</topic><topic>n/a</topic><topic>Nuclear medicine</topic><topic>Patients</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>Prostate cancer</topic><topic>Prostate-Specific Antigen</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Radiation therapy</topic><topic>Signal transduction</topic><topic>Tomography</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>von Eyben, Finn Edler</creatorcontrib><creatorcontrib>Bauman, Glenn</creatorcontrib><creatorcontrib>Kapp, Daniel S</creatorcontrib><creatorcontrib>Virgolini, Irene</creatorcontrib><creatorcontrib>Paganelli, Giovanni</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>von Eyben, Finn Edler</au><au>Bauman, Glenn</au><au>Kapp, Daniel S</au><au>Virgolini, Irene</au><au>Paganelli, Giovanni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>On the Way for Patients with Prostate Cancer to the Best Use of PSMA</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2022-02-24</date><risdate>2022</risdate><volume>23</volume><issue>5</issue><spage>2478</spage><pages>2478-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>In recent years, the prostate-specific membrane antigen (PSMA) has achieved a significant role in the diagnostics and treatments of patients with prostate cancer [...].</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35269620</pmid><doi>10.3390/ijms23052478</doi><orcidid>https://orcid.org/0000-0001-7097-6170</orcidid><orcidid>https://orcid.org/0000-0002-2631-4652</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1422-0067 |
| ispartof | International journal of molecular sciences, 2022-02, Vol.23 (5), p.2478 |
| issn | 1422-0067 1661-6596 1422-0067 |
| language | eng |
| recordid | cdi_doaj_primary_oai_doaj_org_article_a567ef2368fa465988ae08a5514ca10a |
| source | Publicly Available Content Database; PubMed Central(OpenAccess) |
| subjects | Androgen receptors Androgens Animal models Antigens Cancer therapies Clinical trials Computed tomography Conflicts of interest FDA approval Humans Ligands Male Metastasis Molecular structure n/a Nuclear medicine Patients Positron emission Positron emission tomography Prostate cancer Prostate-Specific Antigen Prostatic Neoplasms - diagnosis Prostatic Neoplasms - therapy Radiation therapy Signal transduction Tomography Urology |
| title | On the Way for Patients with Prostate Cancer to the Best Use of PSMA |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A10%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=On%20the%20Way%20for%20Patients%20with%20Prostate%20Cancer%20to%20the%20Best%20Use%20of%20PSMA&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=von%20Eyben,%20Finn%20Edler&rft.date=2022-02-24&rft.volume=23&rft.issue=5&rft.spage=2478&rft.pages=2478-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23052478&rft_dat=%3Cproquest_doaj_%3E2638712682%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-9f1438bf644dc88f9281927928f0540613429b83d549259e3dad40c44db974fc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2637741116&rft_id=info:pmid/35269620&rfr_iscdi=true |